Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 3—March 2009

Research

Coccidioidal Pneumonia, Phoenix, Arizona, USA, 2000–2004

Michelle M. Kim1, Janis E. BlairComments to Author , Elizabeth J. Carey, Qing Wu, and Jerry D. Smilack
Author affiliations: Mayo Clinic, Scottsdale, Arizona, USA

Main Article

Table 2

Characteristics of 35 CAP patients with or without coccidioidomycosis, Phoenix, Arizona, USA, 2000–2004*

Characteristic No. patients
p value
With coccidioidomycosis (n = 6†) Without coccidioidomycosis (n = 29†)
Age, y, mean (range) 59.2 (38.0–80.3) 67.8 (61.8–73.8) 0.25
Male sex 2 (33) 13 (45) 0.60
White race
6 (100)
27 (93)
0.50
Location where evaluated
Hospital 4 (67) 20 (69) 0.99
Emergency department 1 (17) 3 (10) 0.55
Outpatient clinic
1 (17)
6 (21)
0.99
Signs and symptoms
Cough 4 (67) 27 (93) 0.12
Sputum production 1 (17) 16 (55) 0.18
Dyspnea 6 (100) 18 (62) 0.21
Fever 5 (83) 21 (72) 0.99
Chills 3 (50) 11 (38) 0.98
Night sweats 2 (33) 7 (24) 0.99
Rash
3 (50)
0
0.002
Chest radiograph findings
Unilateral infiltrates 5 (83) 17 (59) 0.50
Bilateral infiltrates
1 (17)
8 (28)
0.96
Laboratory results
Leukocyte count, ×109 cells/L, mean (range) 15.1‡ (9.1–21.2) 11.0§ (9.1–12.9) 0.07
Absolute eosinophil count, ×109 cells/L, mean (range)
2.96¶ (0.18–13)
0.12# (0.0–0.2)
0.32
Empiric coccidioidal treatment prescribed after initial visit 1 (17) 1 (3) 0.76

*CAP, community-acquired pneumonia. Values are no. (%) unless otherwise indicated.
†Unless otherwise indicated.
‡n = 6.
§n = 25.
¶n = 5.
#n = 22.

Main Article

1Current affiliation: Kirksville College of Osteopathic Medicine, Kirksville, Missouri, USA.

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO